|
|
|
常見的血液腫瘤主要包括各類白血病、多發性脊髓瘤以及惡性淋巴瘤。急性白血病占常見惡性腫瘤的第八位，淋巴瘤也是在前十位，并且發病率逐年升高，多發性骨髓瘤的整個發病率在血液惡性腫瘤里面占10%。
以下產品可用于多種常見血液腫瘤研究，急性淋巴細胞白血病（Acute Lymphoblastic Leukemia (ALL)是一種起源于淋巴細胞的B系或T系細胞在骨髓內異常增生的惡性腫瘤疾病。異常增生的原始細胞可在骨髓聚集并抑制正常造血功能，同時也可侵及骨髓外的組織，如腦膜、淋巴結、性腺、肝等。急性髓細胞白血病(acute myelocytic leukemia，AML)包括所有非淋巴細胞來源的急性白血病，是多能干細胞或已輕度分化的前體細胞核型發生突變所形成的一類疾病是造血系統的克隆性惡性疾病。淋巴瘤（Lymphoma）是起源于淋巴造血系統的惡性腫瘤，主要表現為無痛性淋巴結腫大，肝脾腫大。
相關產品列表： |
|
急性淋巴細胞白血病相關抗體 |
|
Antibody |
Catalog No. |
Host |
Clone |
Reactivity |
Tested Application/s |
|
CD3 |
NBP2-25186 |
Ms |
OKT3 |
Hu |
FLOW |
|
CD19 |
NBP2-25196 |
Ms |
CD19 |
Hu |
FLOW, IHC |
|
IL2RA/CD25 |
NBP2-27425 |
Rt |
PC61 |
Ms |
FLOW |
|
CD44 |
NBP1-47386 |
Ms |
8E2F3 |
Hu, Ms, Ca, Rb, Eq |
WB, ELISA, FLOW, ICC/IF, IHC, IHC-P |
|
Notch-1 |
NB100-78486 |
Ms |
mN1A |
Hu, Ms |
WB, FLOW, ICC/IF, IHC, IHC-P, IP |
|
|
急性髓細胞樣白血病相關抗體 |
|
Antibody |
Catalog No. |
Host |
Clone |
Reactivity |
Tested Application/s |
|
c-Kit |
NB100-77477 |
Rt |
2B8 |
Hu, Ms |
FLOW, IHC, IHC-Fr, IP |
|
ETV6/Tel |
NBP1-80695 |
Rb |
poly |
Hu, Rt |
WB, ICC/IF, IHC, IHC-P |
|
Flt3/CD135 |
NBP1-43352 |
Rt |
A2F10 |
Ms |
FLOW, Func, IP |
|
Nucleophosmin |
NB110-61646 |
Rb |
poly |
Hu, Ms |
WB, FLOW, ICC/IF, IHC, IHC-P, IP |
|
RUNX1 |
NB100-2044 |
Rb |
poly |
Hu, Ms |
WB |
|
|
淋巴瘤相關抗體 |
|
Antibody |
Catalog No. |
Host |
Clone |
Reactivity |
Tested Application/s |
|
Bcl2 |
NB100-56098 |
Rb |
poly |
Hu, Bv, Ca, Fe |
WB, IHC, IHC-P, IP |
|
CD5 |
NBP2-02690 |
Ms |
7A7 |
Hu |
WB, FLOW, ICC/IF, IHC, IHC-P |
|
CD10 |
NBP1-47356 |
Ms |
2A1H5E1 |
Hu |
WB, ELISA, ICC/IF, IHC, IHC-P |
|
CD15 |
NBP1-28441 |
Ms |
28 |
Hu |
FLOW, IHC, IHC-Fr, IP |
|
CD30 |
NBP2-29425 |
Ms |
CD30/412 |
Hu |
ELISA, FLOW, ICC/IF, IHC-Fr, IHC-P |
|
|
多發性骨髓瘤相關抗體 |
|
Antibody |
Catalog No. |
Host |
Clone |
Reactivity |
Tested Application/s |
|
beta 2 microglobulin |
NB500-317 |
Ms |
B2M-01 |
Hu |
WB, ELISA, FLOW, IHC, IHC-P, IP, RIA |
|
CD38 |
NBP2-25250 |
Ms |
1G7F4 |
Hu, Ms |
WB, IHC, IHC-P |
|
CD56 + NCAM-1 |
NBP2-15184 |
Ms |
123C3 |
Hu, Rt, Ze |
WB, ELISA, FLOW, ICC/IF, IHC-Fr, IHC-P, IP |
|
IL-6 |
NB600-1131 |
Rb |
poly |
Hu, Ms, Rt |
WB, ELISA, ICC/IF, IHC, IHC-P, IP |
|
Syndecan 1 |
NBP1-54523 |
Ms |
MI15 |
Hu |
FLOW, ICC/IF, IHC, IHC-P |
|
|
|
|
CD3 NBP02-25186 |
CD10 NBP1-47356 |
IL-6 NB600-1131 |
|
|
關注Novus疾病研究（http://www.novusbio.com/Hematological-Cancers ）查詢更多與血液腫瘤相關的基因、通路、文獻及產品等信息。 |
